3.905
Schlusskurs vom Vortag:
$4.08
Offen:
$4.11
24-Stunden-Volumen:
1.80M
Relative Volume:
1.74
Marktkapitalisierung:
$326.56M
Einnahmen:
$195.82M
Nettoeinkommen (Verlust:
$-88.78M
KGV:
-1.5565
EPS:
-2.5089
Netto-Cashflow:
$-88.86M
1W Leistung:
-36.50%
1M Leistung:
-29.00%
6M Leistung:
-8.97%
1J Leistung:
-23.28%
Aurora Cannabis Inc. Stock (ACB) Company Profile
Firmenname
Aurora Cannabis Inc.
Sektor
Telefon
-
Adresse
10355 Jasper Avenue, Suite 500, Edmonton, AB
Vergleichen Sie ACB mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ACB
Aurora Cannabis Inc.
|
3.9014 | 326.56M | 195.82M | -88.78M | -88.86M | -2.5089 |
![]()
RGC
Regencell Bioscience Holdings Ltd
|
21.69 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
![]()
ZTS
Zoetis Inc
|
157.87 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.46 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-11 | Eingeleitet | TD Cowen | Buy |
2024-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
2022-09-21 | Hochstufung | Canaccord Genuity | Sell → Hold |
2022-06-24 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2022-06-06 | Hochstufung | Stifel | Sell → Hold |
2021-09-28 | Hochstufung | MKM Partners | Sell → Neutral |
2021-09-03 | Hochstufung | Jefferies | Underperform → Hold |
2021-05-14 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
2021-05-14 | Herabstufung | Canaccord Genuity | Hold → Sell |
2021-05-11 | Herabstufung | CIBC | Neutral → Sector Underperform |
2021-04-28 | Fortgesetzt | BofA Securities | Neutral |
2021-02-12 | Herabstufung | Desjardins | Hold → Sell |
2021-02-12 | Herabstufung | MKM Partners | Neutral → Sell |
2021-02-12 | Herabstufung | Needham | Hold → Underperform |
2020-12-18 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
2020-11-11 | Herabstufung | Stifel | Hold → Sell |
2020-10-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
2020-09-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2020-06-24 | Hochstufung | Stifel | Sell → Hold |
2020-05-22 | Herabstufung | Jefferies | Hold → Underperform |
2020-05-15 | Hochstufung | Piper Sandler | Underweight → Neutral |
2020-02-27 | Herabstufung | Bryan Garnier | Neutral → Sell |
2020-02-25 | Eingeleitet | Needham | Hold |
2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
2020-02-14 | Hochstufung | MKM Partners | Sell → Neutral |
2020-02-07 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
2020-01-10 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2020-01-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
2019-12-23 | Herabstufung | Jefferies | Buy → Hold |
2019-11-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
2019-09-24 | Eingeleitet | CIBC | Neutral |
Alle ansehen
Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten
Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus
Aurora Cannabis Reports Record Revenue and Growth - TipRanks
Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann
Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine
Aurora Cannabis announces new strategic partnership - Investing.com
Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus
Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks
Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com
Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider
Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com
Cannabis Stock Movers For June 18, 2025 - Benzinga
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga
Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg
Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN
Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus
Aurora Cannabis Inc. - Baystreet.ca
Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks
Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se
Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq
ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus
Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com
Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus
Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus
ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha
Aurora Cannabis Files Full Year Results And Announces Fiscal 2025 Fourth Quarter - Barchart.com
Germany Legal Cannabis Market Report 2025-2030: Competitive - GlobeNewswire
Aurora Cannabis (ACB) Prepares for Earnings Announcement - GuruFocus
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday By Investing.com - Investing.com Nigeria
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday - Investing.com
Cannabis Hyperemesis Syndrome Class Action Certified - mg Magazine
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome - Cannabis Health News
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 Earnings - Yahoo Finance
Aurora Cannabis: Poised For Its First Profitable Year (NASDAQ:ACB) - Seeking Alpha
Earnings week ahead: KR, ACN, ACB, and more (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday - MarketBeat
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - The Globe and Mail
Finanzdaten der Aurora Cannabis Inc.-Aktie (ACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):